Cytokinetics, Incorporated · NASDAQ:CYTK
Kaye Edward M. MD received 151 Cytokinetics, Incorporated shares as an award (Form 4)
Traded Jul 15, 2026 · Filed Jul 16, 2026
On Jul 15, 2026, Kaye Edward M. MD (Director) received 151 Cytokinetics, Incorporated shares as an award at US$82.62 for US$12,476, leaving 10,434 shares. Filed Jul 16, 2026 (Form 4).
- Awarded
- 151 shares
- Price
- US$82.62
- Value
- US$12,476
- Holding after
- 10,434 shares
- Trading plan
- No
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jul 15, 2026 | Common Stock | Award | 151 | US$82.62 | 10,434 | Direct |
Source
Related
- Cytokinetics, Incorporated
- Kaye Edward M. MD
- Cytokinetics, Incorporated shareholders
- Form 4 · Kaye Edward M. MD · Oct 20, 2026
- Form 4 · Kaye Edward M. MD · Jun 1, 2026
- Form 4 · Kaye Edward M. MD · May 27, 2026
- Form 4 · Kaye Edward M. MD · Apr 15, 2026
- Form 4 · Malik Fady Ibraham · Oct 20, 2026
- Form 4 · Daly James M · Oct 20, 2026
- Form 4 · Henderson John T · Oct 20, 2026
- Form 4 · Wysenski Nancy · Oct 20, 2026
- Form 4 · Harrington Robert Arthur · Oct 20, 2026